However, CD8+ T cell reactivity against other viral antigens from BK, AdV and EBV was often detectable in the same assay, suggesting that the pattern of recognition is virus- and donor-specific (14) CD4+ T cells might be critical for favorable outcomes of COVID-19 (14) and for vaccine responses (59). The gene discussed is CD4; the disease is COVID-19.